A carregar...
Transthyretin cardiac amyloidosis: an update on diagnosis and treatment
Transthyretin cardiac amyloidosis (ATTR‐CA) demonstrates progressive, potentially fatal, and infiltrative cardiomyopathy caused by extracellular deposition of transthyretin‐derived insoluble amyloid fibrils in the myocardium. Two distinct types of transthyretin (wild type or variant) become unstable...
Na minha lista:
| Publicado no: | ESC Heart Fail |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6989279/ https://ncbi.nlm.nih.gov/pubmed/31553132 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12518 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|